Cite
MLA Citation
F. Spriano et al.. “THE FIRST‐IN‐CLASS ETS INHIBITOR TK‐216 INTERFERES WITH ETS TRANSCRIPTION FACTORS AND SYNERGIZE WITH LENALIDOMIDE IN LYMPHOMA.” Hematological oncology, vol. 37, n.d., p. 322. http://access.bl.uk/ark:/81055/vdc_100086207301.0x000041